Market cap
$551 Mln
Revenue (TTM)
$259 Mln
P/E Ratio
26.1
P/B Ratio
0
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
0.1 %
-
ROCE
-- %
-
Industry P/E
30.2
-
EV/EBITDA
0
-
Debt to Equity
0.2
-
Book Value
$--
-
EPS
$0.4
-
Face value
--
-
Shares outstanding
54,036,800
Years Aggregate
CFO
$--
EBITDA
$--
Net Profit
$--
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Thorne HealthTech Inc (THRN)
| 180.7 | 0.0 | 106.7 | 121.5 | -- | -- | -4.2 |
|
BSE Sensex*
| -12.3 | -3.4 | -8.6 | -8.8 | 5.8 | 7.4 | 10.8 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2022
|
2016
|
|---|---|---|
|
Thorne HealthTech Inc (THRN)
| -41.5 | 10.3 |
|
S&P Small-Cap 600
| -17.4 | 24.7 |
|
BSE Sensex
| 4.4 | 1.9 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Shareholding Pattern
View DetailsAbout Thorne HealthTech Inc (THRN)
Thorne HealthTech, Inc., a science-driven wellness company, provides solutions and personalized approaches to health and wellness in the United States and internationally. It offers various health tests, such as sleep, stress, weight management, gut... health, heavy metals, biological age, and other health tests that generate molecular portraits for its customers, as well as develops nutritional supplements and offers wellness education solutions. The company uses the Onegevity platform to map, integrate, and understand the biological features that describe the state of an individual's health, as well as provide actionable insights and personalized data, products, and services that help individuals to take a proactive approach to enhance and maintain their health. It primarily serves healthcare professionals, professional athletes, and professional sports and Olympic teams. Thorne HealthTech, Inc. was founded in 1984 and is headquartered in New York, New York. Read more
-
Co-Founder, CEO & Chairman
Mr. Paul F. Jacobson
-
Pres
Mr. William C. McCamy
-
Headquarters
New York, NY
-
Website
FAQs for Thorne HealthTech Inc (THRN)
What is the current share price of Thorne HealthTech Inc (THRN) Today?
The share price of Thorne HealthTech Inc (THRN) is $10.19 (NASDAQ) as of 16-Oct-2023 09:30 EDT. Thorne HealthTech Inc (THRN) has given a return of 121.52% in the last 1 years.
What is the current PB & PE ratio of Thorne HealthTech Inc (THRN)?
The P/E ratio of Thorne HealthTech Inc (THRN) is 26.13 times as on 16-Oct-2023, a 13 discount to its peers’ median range of 30.20 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2022
|
12.27
|
1.33
|
|
2021
|
34.66
|
3.07
|
|
2020
|
--
|
--
|
|
2019
|
--
|
--
|
|
2022
|
12.27
|
1.33
|
What is the 52 Week High and Low of Thorne HealthTech Inc (THRN)?
The 52-week high and low of Thorne HealthTech Inc (THRN) are Rs -- and Rs -- as of 01-Jun-2026.
What is the market cap of Thorne HealthTech Inc (THRN)?
Thorne HealthTech Inc (THRN) has a market capitalisation of $ 551 Mln as on 16-Oct-2023. As per SEBI classification, it is a Small Cap company.
Should I invest in Thorne HealthTech Inc (THRN)?
Before investing in Thorne HealthTech Inc (THRN), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.